Case report: sequential use of almonertinib based on the  EGFR  exon 20 insertion mutation achieves long-term control for advanced non-small cell lung cancer patients

Ruilin Wang, Sheng Yu, Limeng Yu, Jiuzhou Zhao, Shuyue Jiao, Qiming Wang, Yufeng Wu